In-vitro antimicrobial activity of HSR-903, a new fluoroquinolone, against clinical isolates of Klebsiella pneumoniae and Enterobacter cloacae with fluoroquinolone resistance-associated amino acid alterations in GyrA and ParC.
Deguchi
T
T
Yasuda
M
M
Kawamura
T
T
Takahashi
Y
Y
Okezaki
E
E
Nagata
O
O
Kato
H
H
Kawada
Y
Y
D000890:Anti-Infective Agents / Q000494:pharmacology*; D027081:DNA Gyrase; D027101:DNA Topoisomerase IV; D004250:DNA Topoisomerases, Type II / Q000235:genetics; D004352:Drug Resistance, Microbial; D016972:Enterobacter cloacae / Q000187:drug effects* / Q000235:genetics; D024841:Fluoroquinolones; D007711:Klebsiella pneumoniae / Q000187:drug effects* / Q000235:genetics; D008826:Microbial Sensitivity Tests; D015363:Quinolones / Q000494:pharmacology*; D017386:Sequence Homology, Amino Acid
D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D015363:Quinolones; D027101:DNA Topoisomerase IV; D027081:DNA Gyrase; D004250:DNA Topoisomerases, Type II; C106426:olamufloxacin